ArticleJournal of translational medicine2024

Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I/R) injury.

Jianjun Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.